225 related articles for article (PubMed ID: 17804715)
1. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.
Yu YP; Yu G; Tseng G; Cieply K; Nelson J; Defrances M; Zarnegar R; Michalopoulos G; Luo JH
Cancer Res; 2007 Sep; 67(17):8043-50. PubMed ID: 17804715
[TBL] [Abstract][Full Text] [Related]
2. p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3.
Wang H; Luo K; Tan LZ; Ren BG; Gu LQ; Michalopoulos G; Luo JH; Yu YP
J Biol Chem; 2012 May; 287(20):16890-902. PubMed ID: 22461624
[TBL] [Abstract][Full Text] [Related]
3. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
4. Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer.
Zhao H; Li J; Li X; Han C; Zhang Y; Zheng L; Guo M
Curr Protein Pept Sci; 2015; 16(4):316-21. PubMed ID: 25929866
[TBL] [Abstract][Full Text] [Related]
5. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
Jarrard DF; Bova GS; Ewing CM; Pin SS; Nguyen SH; Baylin SB; Cairns P; Sidransky D; Herman JG; Isaacs WB
Genes Chromosomes Cancer; 1997 Jun; 19(2):90-6. PubMed ID: 9171999
[TBL] [Abstract][Full Text] [Related]
6. CSR1 suppresses tumor growth and metastasis of prostate cancer.
Yu G; Tseng GC; Yu YP; Gavel T; Nelson J; Wells A; Michalopoulos G; Kokkinakis D; Luo JH
Am J Pathol; 2006 Feb; 168(2):597-607. PubMed ID: 16436673
[TBL] [Abstract][Full Text] [Related]
7. Glutathione Peroxidase 3 Inhibits Prostate Tumorigenesis in TRAMP Mice.
Chang SN; Lee JM; Oh H; Park JH
Prostate; 2016 Nov; 76(15):1387-98. PubMed ID: 27325372
[TBL] [Abstract][Full Text] [Related]
8. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice.
Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH
Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105
[TBL] [Abstract][Full Text] [Related]
9. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
10. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer.
Zhang X; Zheng Z; Yingji S; Kim H; Jin R; Renshu L; Lee DY; Roh MR; Yang S
Oncol Rep; 2014 Jun; 31(6):2587-92. PubMed ID: 24788695
[TBL] [Abstract][Full Text] [Related]
12. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation and downregulation of glutathione peroxidase 3 are related to pathogenesis of melanoma.
Chen H; Zheng Z; Kim KY; Jin X; Roh MR; Jin Z
Oncol Rep; 2016 Nov; 36(5):2737-2744. PubMed ID: 27600457
[TBL] [Abstract][Full Text] [Related]
14. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic and Glucocorticoid Receptor-Mediated Regulation of Glutathione Peroxidase 3 in Lung Cancer Cells.
An BC; Jung NK; Park CY; Oh IJ; Choi YD; Park JI; Lee SW
Mol Cells; 2016 Aug; 39(8):631-8. PubMed ID: 27484907
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer.
Min SY; Kim HS; Jung EJ; Jung EJ; Jee CD; Kim WH
Anticancer Res; 2012 Aug; 32(8):3169-75. PubMed ID: 22843889
[TBL] [Abstract][Full Text] [Related]
18. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
[TBL] [Abstract][Full Text] [Related]
19. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
20. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells.
Kuzmin I; Gillespie JW; Protopopov A; Geil L; Dreijerink K; Yang Y; Vocke CD; Duh FM; Zabarovsky E; Minna JD; Rhim JS; Emmert-Buck MR; Linehan WM; Lerman MI
Cancer Res; 2002 Jun; 62(12):3498-502. PubMed ID: 12067994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
